Compare SPRO & EFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SPRO | EFSI |
|---|---|---|
| Founded | 2013 | 1881 |
| Country | United States | United States |
| Employees | N/A | 231 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 156.3M | 185.5M |
| IPO Year | 2017 | N/A |
| Metric | SPRO | EFSI |
|---|---|---|
| Price | $2.20 | $41.64 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $41.50 |
| AVG Volume (30 Days) | ★ 1.6M | 29.6K |
| Earning Date | 05-13-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.26% |
| EPS Growth | ★ 111.81 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $66,802,000.00 | N/A |
| Revenue This Year | N/A | $31.93 |
| Revenue Next Year | $300.00 | $4.38 |
| P/E Ratio | ★ N/A | $24.38 |
| Revenue Growth | ★ 39.24 | N/A |
| 52 Week Low | $1.80 | $28.98 |
| 52 Week High | $3.09 | $44.00 |
| Indicator | SPRO | EFSI |
|---|---|---|
| Relative Strength Index (RSI) | 36.21 | 61.53 |
| Support Level | $2.19 | $38.38 |
| Resistance Level | $2.47 | N/A |
| Average True Range (ATR) | 0.26 | 1.18 |
| MACD | -0.07 | -0.02 |
| Stochastic Oscillator | 22.29 | 55.26 |
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.
Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending and Wealth Management. It generates a majority of its revenue from the Community Banking segment.